SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-074975
Filing Date
2016-01-11
Accepted
2016-01-11 07:33:17
Documents
8
Period of Report
2016-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v428626_8k.htm 8-K 42391
2 EXHIBIT 3.1 v428626_ex3-1.htm EX-3.1 40056
3 EXHIBIT 4.1 v428626_ex4-1.htm EX-4.1 116077
4 EXHIBIT 4.2 v428626_ex4-2.htm EX-4.2 123878
5 EXHIBIT 4.3 v428626_ex4-3.htm EX-4.3 123044
6 EXHIBIT 4.4 v428626_ex4-4.htm EX-4.4 94472
7 EXHIBIT 10.1 v428626_ex10-1.htm EX-10.1 258805
8 EXHIBIT 99.1 v428626_ex99-1.htm EX-99.1 9202
  Complete submission text file 0001144204-16-074975.txt   809251
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 161335060
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences